Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
✍ Scribed by Capello, Michela; Cappello, Paola; Linty, Federica; Chiarle, Roberto; Sperduti, Isabella; Novarino, Anna; Salacone, Paola; Mandili, Giorgia; Naccarati, Alessio; Sacerdote, Carlotta; Beghelli, Stefania; Bersani, Samantha; Barbi, Stefano; Bassi, Claudio; Scarpa, Aldo; Nisticò, Paola; Giovarelli, Mirella; Vineis, Paolo; Milella, Michele; Novelli, Francesco
- Book ID
- 121624607
- Publisher
- BioMed Central
- Year
- 2013
- Tongue
- English
- Weight
- 744 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1756-8722
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Because of the poor prognosis and the development of resistance against chemotherapeutic drugs, the current treatment for advanced metastatic colorectal cancer (CRC) is ineffective. Whether curcumin (a component of turmeric) can potentiate the effect of capecitabine against growth and m